Vaccines Market by Patient Type [Pediatric Patients and Adult Patients], Strain Type [Monovalent Vaccines and Multivalent Vaccines], Technology [Live Attenuated Vaccines, Conjugate Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Inactivated & Subunit Vaccines], Vaccine Type [DT Containing Vaccine; Measles, Mumps, Rubella, Varicella; Pneumococcal Conjugate Vaccine (PCV); Human Papillomavirus (HPV); Meningococcal; COVID-19; Rotavirus; Hepatitis and Influenza], Route of Administration [Oral and Parenteral] – Global Analysis & Forecast 2021-2031
Vaccine is a biological preparation that provides active acquired immunity to a particular disease. It helps the body’s immune system to recognize and fight pathogens like viruses or bacteria, which keeps us safe from the diseases they cause. Vaccines are made using the disease-causing virus or bacteria, but in a form that will not harm human body. Instead, the weakened, killed, or partial virus or bacteria prompts human body immune system to develop antibodies, or defenders, against the disease. Vaccination is one of the most effective ways to prevent diseases. Vaccines protect against debilitating or life-threatening diseases, including measles, polio, tetanus, diphtheria, meningitis, influenza, tetanus, typhoid, COVID-19, cervical cancer, etc. Vaccines are generally prepared by using five major technologies i.e., conjugate vaccines, live attenuated vaccines, toxoid vaccines, inactivated and subunit vaccines and recombinant vaccines.
The global vaccines market is mainly driven by outbreak of infectious diseases in different regions, rising awareness for immunization, growing number of new born babies globally, robust vaccine pipeline and various initiatives for making vaccine available to low- and middle-income countries. Furthermore, increasing government support for vaccine development is also playing a pivotal role in contributing to growth of the market globally. However, high cost of vaccine development and religious beliefs among certain communities regarding vaccination are likely to restrain the market growth to a certain extent.
The global vaccines market has been analyzed from six perpectives: Patient Type, Strain Type, Technology, Vaccine Type, Route of Administration and Region.
Based on patient type, the market has been segmented into pediatric patients and adult patients. The pediatric patients segment accounted for the largest share in the market owing to rising pediatric population and growing initiatives by public & private organizations to promote childhood immunization.
Based on strain type, the market has been segmented into monovalent vaccines and multivalent vaccines. The multivalent vaccines segment accounted for the largest share and is expected to be the fastest growing segment in the market during the forecast period owing to extensive development of innovative multivalent vaccines. Multivalent vaccines provide immunity against two or more strains of the same pathogen, or against two or more pathogens.
Based on technology, the vaccines market has been segmented into live attenuated vaccines, conjugate vaccines, recombinant vaccines, toxoid vaccines, inactivated and subunit vaccines. Recombinant vaccines segment is expected to be the fastest growing segment in the market during the forecast period. The growth of the segment can mainly be attributed to development and launch of several recombinant vaccines. Recombinant vaccines are developed by the application of recombinant DNA technology. It involves the insertion of DNA which encodes an antigen for the stimulation of immune response against the expressed antigen.
Based on vaccine type, the vaccines market has been segmented into DT containing vaccine; measles, mumps, rubella, varicella; pneumococcal conjugate vaccine (PCV); human papillomavirus (HPV); meningococcal; COVID-19; rotavirus; hepatitis; influenza and others (cholera, malaria, rabies, shingles, etc.). The COVID-19 segment is expected to be the fastest growing segment in the market during the forecast period. The growth of the segment can be attributed to the sudden outbreak of the COVID-19 pandemic globally; increasing investments, collaboration & funding to boost R&D activities for development of effective COVID-19 vaccine; and rising initiatives by various government bodies & numerous organizations to provide COVID-19 immunization worldwide.
Based on route of administration, the vaccines market has been segmented into oral and parenteral. The parenteral segment holds the largest share in the market. Intramuscular administration is often preferred because it is easy to perform and generally well tolerated, with a low risk for adverse reactions at the site of injection. The majority of licensed vaccines in market are administered by intramuscular injection, whereas some vaccines are approved for subcutaneous or intradermal use.
Based on region, the global vaccines market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the vaccines market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to its developed healthcare infrastructure, presence of prominent players, and increasing government initiative for immunization programmes. According to CDC, around 70% of children aged 19-35 months has received a complete seven-vaccine series (a subset of all recommended vaccinations for this age group) in the U.S.
The vaccines market is marked by presence of prominent players such as Merck & Co., Sanofi, GlaxoSmithKline plc., Pfizer Inc., AstraZeneca, CSL Limited, Panacea Biotec Ltd., Serum Institute of India Pvt. Ltd., PT Bio Farma (Persero), Bavarian Nordic, among others. Other players operating in the market are Bharat Biotech, Emergent BioSolutions Inc., Johnson & Johnson Private Limited, Mitsubishi Tanabe Pharma Corporation, among others.
|Market Size Period||2018-2031|
|Market Segments||Asessment of Vaccines Market By:
• Patient Type
• Strain Type
• Vaccine Type
|Geographic Scope||• North America
◦ Rest of Europe (RoE)
• Asia Pacific
◦ Rest of Asia Pacific (RoAPAC)
• Rest of the World
◦ Latin America
◦ Middle East & Africa
|Companies Covered||Merck & Co., Sanofi, GlaxoSmithKline plc., Pfizer Inc., AstraZeneca, CSL Limited, Panacea Biotec Ltd., Serum Institute of India Pvt. Ltd., PT Bio Farma (Persero), Bavarian Nordic, Bharat Biotech, Emergent BioSolutions Inc., Johnson & Johnson Private Limited, Mitsubishi Tanabe Pharma Corporation, among others.|
1 RESEARCH ENVELOPE
1.1 Market Classification
1.2 Scope of the Study
1.2.1 Timeline Considered for Market Study
· Historic Years – 2018 & 2019
· Base Year – 2020
· Projected Years – 2021 to 2031
1.3 Currency Used in the Report
2 RESEARCH METHODOLOGY
2.1 Research Approach
2.2 Data Collection Methodology
2.3 Data Sources
2.3.1 Secondary Sources
2.3.2 Primary Sources
2.4 Market Crackdown Methodology
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Forecasting Model
2.6 Limitations and Assumptions for Study
3 HEADWINDS & TAILWINDS ASSESSMENT
4 MARKET OPPORTUNITIES ASSESSMENT
5 PREMIUM INSIGHTS
5.1 Key Market Trends
5.2 Key Players & Their Competitive Positioning (2020)
5.3 COVID-19 Impact Assessment
5.4 Pipeline Assessment
6 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY PATIENT TYPE
6.1 Pediatric Patients
6.2 Adult Patients
7 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY STRAIN TYPE
7.1 Monovalent Vaccines
7.2 Multivalent Vaccines
8 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
8.1 Live Attenuated Vaccines
8.2 Conjugate Vaccines
8.3 Recombinant Vaccines
8.4 Toxoid Vaccines
8.5 Inactivated & Subunit Vaccines
9 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY VACCINE TYPE
9.1 DT Containing Vaccine
9.2 Measles, Mumps, Rubella, Varicella
9.3 Pneumococcal Conjugate Vaccine (PCV)
9.4 Human Papillomavirus (HPV)
9.10 Others (Cholera, Malaria, Rabies, Shingles, Etc.)
10 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
11 GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY REGION
11.1 North America Vaccines Market
11.1.1 North America Vaccines Market, By Country
11.1.2 North America Vaccines Market, By Patient Type
11.1.3 North America Vaccines Market, By Strain Type
11.1.4 North America Vaccines Market, By Technology
11.1.5 North America Vaccines Market, By Vaccine Type
11.1.6 North America Vaccines Market, By Route of Administration
11.2 Europe Vaccines Market
11.2.1 Europe Vaccines Market, By Country/Region
18.104.22.168 Rest of Europe (ROE)
11.2.2 Europe Vaccines Market, By Patient Type
11.2.3 Europe Vaccines Market, By Strain Type
11.2.4 Europe Vaccines Market, By Technology
11.2.5 Europe Vaccines Market, By Vaccine Type
11.2.6 Europe Vaccines Market, By Route of Administration
11.3 Asia Pacific Vaccines Market
11.3.1 Asia Pacific Vaccines Market, By Country/Region
22.214.171.124 Rest of Asia Pacific (RoAPAC)
11.3.2 Asia Pacific Vaccines Market, By Patient Type
11.3.3 Asia Pacific Vaccines Market, By Strain Type
11.3.4 Asia Pacific Vaccines Market, By Technology
11.3.5 Asia Pacific Vaccines Market, By Vaccine Type
11.3.6 Asia Pacific Vaccines Market, By Route of Administration
11.4 Rest of the World (RoW) Vaccines Market
11.4.1 Rest of the World Vaccines Market, By Region
126.96.36.199 Latin America
188.8.131.52 Middle East & Africa
11.4.2 Rest of The World Vaccines Market, By Patient Type
11.4.3 Rest of The World Vaccines Market, By Strain Type
11.4.4 Rest of The World Vaccines Market, By Technology
11.4.5 Rest of The World Vaccines Market, By Vaccine Type
11.4.6 Rest of The World Vaccines Market, By Route of Administration
12 COMPANY PROFILES
12.1 Merck & Co.
12.1.1 Business Overview
12.1.2 Financial Metrics*
12.1.3 Product Portfolio
12.1.4 Key Developments
12.3 GlaxoSmithKline plc.
12.4 Pfizer Inc.
12.6 CSL Limited
12.7 Panacea Biotec Ltd.
12.8 Serum Institute of India Pvt. Ltd.
12.9 PT Bio Farma (Persero)
12.10 Bavarian Nordic
*Insights on financial metrics is subject to availability of information in the public domain
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...